Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ODEVIXIBAT vs OLMESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ODEVIXIBAT vs OLMESARTAN: Safety Overview

Metric ODEVIXIBAT OLMESARTAN
Total FAERS Reports 223 2,228
Deaths Reported 10 77
Death Rate 4.5% 3.5%
Hospitalizations 43 1,096
Average Patient Age 14.3 yrs 68.9 yrs
% Female Patients 49.4% 52.8%
FDA Approval Date Jul 20, 2021 N/A
Manufacturer Albireo Pharma, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A